Tango Therapeutics logo

Tango Therapeutics share price today

(TNGX)

Tango Therapeutics share price is $3.1 & ₹263.43 as on 21 Dec 2024, 2.30 'hrs' IST

$3.1

0.16

(5.44%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Tango Therapeutics share price in Dollar and Rupees. Guide to invest in Tango Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Tango Therapeutics. Get details on the Indian mutual funds that are investing in Tango Therapeutics. Get Analyst recommendations and forecasts along with all the Tango Therapeutics's financials.

Tango Therapeutics share price movements

  • Today's Low: $2.88
    Today's High: $3.13

    Day's Volatility :8.0%

  • 52 Weeks Low: $2.70
    52 Weeks High: $13.01

    52 Weeks Volatility :79.24%

Tango Therapeutics Returns

PeriodTango Therapeutics IncIndex (Russel 2000)
3 Months
-59.69%
0.0%
6 Months
-69.46%
0.0%
1 Year
-70.36%
0.0%
3 Years
-71.66%
-19.7%

Tango Therapeutics Key Statistics

in dollars & INR

Previous Close
$2.94
Open
$2.91
Today's High
$3.13
Today's Low
$2.8797
Market Capitalization
$315.8M
Today's Volume
$2.8M
52 Week High
$13.005
52 Week Low
$2.7
Revenue TTM
$43.4M
EBITDA
$-137.2M
Earnings Per Share (EPS)
$-1.15
Profit Margin
-284.43%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-48.79%

How to invest in Tango Therapeutics from India?

It is very easy for Indian residents to invest directly in Tango Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tango Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tango Therapeutics or TNGX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tango Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tango Therapeutics shares which would translate to 0.274 fractional shares of Tango Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Tango Therapeutics, in just a few clicks!

Returns in Tango Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tango Therapeutics investment value today

Current value as on today

₹1,72,559

Returns

₹72,559

(+72.56%)

Returns from Tango Therapeutics Stock

₹70,363 (false-70.36%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Tango Therapeutics

-74%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Tango Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -74% less investors are searching Tango Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Tango Therapeutics

  • TRV GP IV, LLC

    15.69%

  • EcoR1 Capital, LLC

    12.41%

  • FMR Inc

    8.73%

  • Boxer Capital LLC

    7.63%

  • Nextech Invest AG

    5.15%

  • T. Rowe Price Investment Management,Inc.

    4.68%

Analyst Recommendation on Tango Therapeutics

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Tango Therapeutics(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
12
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Tango Therapeutics

What analysts predicted

Upside of 270.97%

Current:

$3.10

Target:

$11.50

Insights on Tango Therapeutics

  • Price Movement

    In the last 3 months, TNGX stock has moved down by -62.7%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 19.87M → 11.60M (in $), with an average decrease of 41.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -25.55M → -29.16M (in $), with an average decrease of 14.2% per quarter
  • TNGX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 103.9%
  • TNGX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 94.6%
  • Price to Sales

    ForTNGX every $1 of sales, investors are willing to pay $7.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Tango Therapeutics Technicals Summary

Sell

Neutral

Buy

Tango Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Tango Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tango Therapeutics Inc
-20.92%
-69.46%
-70.36%
-71.66%
-68.97%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.38%
12.23%
86.41%
Biontech Se
4.48%
30.56%
7.97%
-55.71%
237.85%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.37%
26.29%
108.55%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-2.55%
77.79%
80.12%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tango Therapeutics Inc
NA
NA
NA
-1.21
-0.49
-0.22
NA
2.13
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tango Therapeutics Inc
Buy
$315.8M
-68.97%
NA
-284.43%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
86.41%
17.51
33.61%
Biontech Se
Buy
$26.7B
237.85%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
108.55%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.12%
32.84
-4.51%

About Tango Therapeutics

tango therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. tango was launched in 2017 with a $55 million series a investment from third rock ventures. the company has established a robust product engine that leverages advances in dna sequencing and crispr-based target discovery to generate breakthrough medicines that have the potential to provide deeper, more sustained benefit than today’s targeted therapies, and extend the benefit of available immuno-oncology agents. tango therapeutics is focused on three areas of drug development, each in well-defined patient populations currently lacking effective treatment options, and each with hallmarks of cancer that have not been targeted yet. these include: loss of tumor suppressor gene function; multiple oncogenic drivers; and immune evasion. what fuels each of tango’s programs is an increasingly sophisticated ability to util
Organization
Tango Therapeutics
Employees
140
CEO
Dr. Barbara L. Weber M.D.
Industry
Miscellaneous

Management People of Tango Therapeutics

NameTitle
Dr. Barbara L. Weber M.D.
President, CEO & Director
Dr. Adam S. Crystal M.D., Ph.D.
President of Research & Development
Dr. Alan Ashworth FRS, Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Levi Garraway M.D., Ph.D.
Founder
Dr. William G. Kaelin Jr., M.D.
Founder & Member of Scientific Advisory Board
Dr. Timothy K. Lu M.D., Ph.D.
Founder
Dr. Antoni Ribas M.D., Ph.D.
Founder & Member of Scientific Advisory Board
Mr. Timothy Redfern
Chief Financial Officer
Dr. Michael Palmieri Ph.D.
Head of Technical Operations
Mr. Jannik N. Andersen Ph.D.
Chief Scientific Officer

Important FAQs about investing in Tango Therapeutics from India :

What is Tango Therapeutics share price today?

Tango Therapeutics share price today stands at $3.10, Open: $2.91 ; Previous Close: $2.94 ; High: $3.13 ; Low: $2.88 ; 52 Week High: $13.01 ; 52 Week Low: $2.70. The stock opens at $2.91, after a previous close of $2.94. The stock reached a daily high of $3.13 and a low of $2.88, with a 52-week high of $13.01 and a 52-week low of $2.70.

Can Indians buy Tango Therapeutics shares?

Yes, Indians can invest in the Tango Therapeutics (TNGX) from India.

With INDmoney, you can buy Tango Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Tango Therapeutics at zero transaction cost.

How can I buy Tango Therapeutics shares from India?

It is very easy to buy Tango Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tango Therapeutics be purchased?

Yes, you can buy fractional shares of Tango Therapeutics with INDmoney app.

What are the documents required to start investing in Tango Therapeutics stocks?

To start investing in Tango Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Tango Therapeutics

Today’s highest price of Tango Therapeutics (TNGX) is $3.13.

Today’s lowest price of Tango Therapeutics (TNGX) is $2.88.

What is today's market capitalisation of Tango Therapeutics

Today's market capitalisation of Tango Therapeutics TNGX is 315.8M

What is the 52 Week High and Low Range of Tango Therapeutics

  • 52 Week High

    $13.01

  • 52 Week Low

    $2.70

What are the historical returns of Tango Therapeutics?

  • 1 Month Returns

    -20.92%

  • 3 Months Returns

    -69.46%

  • 1 Year Returns

    -70.36%

  • 5 Years Returns

    -68.97%

Who is the Chief Executive Officer (CEO) of Tango Therapeutics

Dr. Barbara L. Weber M.D. is the current Chief Executive Officer (CEO) of Tango Therapeutics.